Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-14

Clinical Trial Update: Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Praga Formulation for neuropathic pain is currently recruiting. The study, sponsored by EMS, aims to assess the formulation'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Praga Formulation

Snippet

Sponsor: EMS | Conditions: Neuropathic Pain | Phase 3 | Status: RECRUITING